Wilson Parker C, Fitzgibbon Wayne R, Garrett Sara M, Jaffa Ayad A, Luttrell Louis M, Brands Michael W, El-Shewy Hesham M
Department of Pathology (P.C.W.), Yale-New Haven Hospital, New Haven, Connecticut 06510; Departments of Medicine (W.R.F., S.M.G., A.A.J., L.M.L., H.M.E.) and Biochemistry and Molecular Biology (L.M.L.), Medical University of South Carolina, Charleston, South Carolina 29425; Department of Research Service (L.M.L.), Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina 29401; Department of Physiology (M.W.B.), Medical College of Georgia, Georgia Health Sciences University, Augusta, Georgia 30912; and Department of Biochemistry and Molecular Genetics (A.A.J.), Faculty of Medicine, American University of Beirut, Beirut, Lebanon 113-6044.
Mol Endocrinol. 2015 Jun;29(6):896-908. doi: 10.1210/me.2014-1388. Epub 2015 Apr 14.
Angiotensin II (AngII) plays a critical role in the regulation of vascular tone and blood pressure mainly via regulation of Ca(2+) mobilization. Several reports have implicated sphingosine kinase 1 (SK1)/sphingosine 1-phosphate (S1P) in the mobilization of intracellular Ca(2+) through a yet-undefined mechanism. Here we demonstrate that AngII-induces biphasic calcium entry in vascular smooth muscle cells, consisting of an immediate peak due to inositol tris-phosphate-dependent release of intracellular calcium, followed by a sustained transmembrane Ca(2+) influx through store-operated calcium channels (SOCs). Inhibition of SK1 attenuates the second phase of transmembrane Ca(2+) influx, suggesting a role for SK1 in AngII-dependent activation of SOC. Intracellular S1P triggers SOC-dependent Ca(2+) influx independent of S1P receptors, whereas external application of S1P stimulated S1P receptor-dependent Ca(2+) influx that is insensitive to inhibitors of SOCs, suggesting that the SK1/S1P axis regulates store-operated calcium entry via intracellular rather than extracellular actions. Genetic deletion of SK1 significantly inhibits both the acute hypertensive response to AngII in anaesthetized SK1 knockout mice and the sustained hypertensive response to continuous infusion of AngII in conscious animals. Collectively these data implicate SK1 as the missing link that connects the angiotensin AT1A receptor to transmembrane Ca(2+) influx and identify SOCs as a potential intracellular target for SK1.
血管紧张素II(AngII)主要通过调节Ca(2+)动员在血管张力和血压调节中起关键作用。一些报告表明,鞘氨醇激酶1(SK1)/鞘氨醇1-磷酸(S1P)通过一种尚未明确的机制参与细胞内Ca(2+)的动员。在此,我们证明AngII可诱导血管平滑肌细胞出现双相性钙内流,第一相为由于三磷酸肌醇依赖性细胞内钙释放导致的即刻峰值,随后是通过储存-操纵性钙通道(SOCs)的持续跨膜Ca(2+)内流。抑制SK1可减弱跨膜Ca(2+)内流的第二相,提示SK1在AngII依赖性SOC激活中发挥作用。细胞内S1P触发不依赖S1P受体的SOC依赖性Ca(2+)内流,而外源性应用S1P刺激S1P受体依赖性Ca(2+)内流,且该内流对SOC抑制剂不敏感,这表明SK1/S1P轴通过细胞内而非细胞外作用调节储存-操纵性钙内流。SK1基因缺失显著抑制麻醉的SK1基因敲除小鼠对AngII的急性高血压反应以及清醒动物对持续输注AngII的持续性高血压反应。这些数据共同表明SK1是连接血管紧张素AT1A受体与跨膜Ca(2+)内流的缺失环节,并确定SOCs为SK1的潜在细胞内靶点。